Phathom Pharmaceuticals (PHAT) PT Lowered to $44 at Needham & Company to Reflect vonoprazan Launch Dynamic, "Remain Confident in the Commercial Potential"

Go back to Phathom Pharmaceuticals (PHAT) PT Lowered to $44 at Needham & Company to Reflect vonoprazan Launch Dynamic, "Remain Confident in the Commercial Potential"
(NASDAQ: PHAT) Delayed: 9.04 -0.13 (1.42%)
Previous Close $9.17    52 Week High
Open $9.25    52 Week Low
Day High $9.39    P/E N/A 
Day Low $9.02    EPS
Volume 336,034